Abstract
The synthesis and antihypertensive activity of a group of imidazo[1,2-a]pyridine is described. New synthesized compound have been tested both in vivo and in vitro as antagonists on Angiotensin AT1 receptor, and compared to Losartan, used as reference drug. Binding assay an Angiotensin AT1 receptor were carried on as well. Compounds 6b and 6g showed a potent antihypertensive activity and an high affinity on AT1 receptor.
Keywords: AngII AT1 receptor antagonists, antihypertensive in vivo and in vitro activity, imidazo[1,2-a]pyridine, Synthesis and Antihypertensive Action of New Imidazo[1,2-a]pyridine Derivatives, non Peptidic Angiotensin II Receptor, Antagonists, linear octapeptide angiotensin
Cardiovascular & Hematological Disorders-Drug Targets
Title: Synthesis and Antihypertensive Action of New Imidazo[1,2-a]pyridine Derivatives , non Peptidic Angiotensin II Receptor Antagonists
Volume: 11 Issue: 2
Author(s): Sonia Laneri, Cristina Di Ronza, Antonietta Bernardi, Carmine Ostacolo, Antonia Sacchi, Carmela Cervone, Michele D'Amico, Clara Di Filippo, Maria Letizia Trincavelli, Anna Panighini and Claudia Martini
Affiliation:
Keywords: AngII AT1 receptor antagonists, antihypertensive in vivo and in vitro activity, imidazo[1,2-a]pyridine, Synthesis and Antihypertensive Action of New Imidazo[1,2-a]pyridine Derivatives, non Peptidic Angiotensin II Receptor, Antagonists, linear octapeptide angiotensin
Abstract: The synthesis and antihypertensive activity of a group of imidazo[1,2-a]pyridine is described. New synthesized compound have been tested both in vivo and in vitro as antagonists on Angiotensin AT1 receptor, and compared to Losartan, used as reference drug. Binding assay an Angiotensin AT1 receptor were carried on as well. Compounds 6b and 6g showed a potent antihypertensive activity and an high affinity on AT1 receptor.
Export Options
About this article
Cite this article as:
Laneri Sonia, Di Ronza Cristina, Bernardi Antonietta, Ostacolo Carmine, Sacchi Antonia, Cervone Carmela, D'Amico Michele, Di Filippo Clara, Letizia Trincavelli Maria, Panighini Anna and Martini Claudia, Synthesis and Antihypertensive Action of New Imidazo[1,2-a]pyridine Derivatives , non Peptidic Angiotensin II Receptor Antagonists, Cardiovascular & Hematological Disorders-Drug Targets 2011; 11 (2) . https://dx.doi.org/10.2174/187152911798347016
DOI https://dx.doi.org/10.2174/187152911798347016 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Implications of Prion Protein Biology
Current Neurovascular Research Heterozygosity in LDLR rs2228671 and rs72658855 Gene is Associated with Increased Risk of Developing Coronary Artery Disease in India –A Case-Control Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacological and Non Pharmacological Strategies in the Management of Coronary Artery Disease and Chronic Kidney Disease
Current Cardiology Reviews The Role of Infection in Carotid Plaque Pathogenesis and Stability: The Clinical Evidence
Current Vascular Pharmacology Transdermal Delivery of Captopril and Metoprolol Tartrate with Microneedles
Drug Delivery Letters Platelet-Derived Chemokines in Atherogenesis: What’s New?
Current Vascular Pharmacology Bridging Intravenous Thrombolysis Before Mechanical Thrombectomy for Large Artery Occlusion May be Detrimental with Thrombus Fragmentation
Current Neurovascular Research Physical Work and Exercise Reduce the Risk of Cognitive Impairment in Older Adults: A Population-based Longitudinal Study
Current Alzheimer Research Telmisartan, its Potential Therapeutic Implications in Cardiometabolic Disorders
Recent Patents on Cardiovascular Drug Discovery Antiplatelet Therapy And Percutaneous Coronary Interventions
Current Cardiology Reviews Hypothalamic Leptin and Ghrelin Signaling as Targets for Improvement in Metabolic Control
Current Pharmaceutical Design Motion Analysis of the Carotid Artery Wall and Plaque Using B-Mode Ultrasound
Vascular Disease Prevention (Discontinued) Expression and Function of the Endocannabinoid System in Glial Cells
Current Pharmaceutical Design Use of Antiplatelet Therapy after Percutaneous Coronary Intervention with Bare-Metal Stents and Different Types of Drug-Eluting Stents
Current Clinical Pharmacology Modulators of Voltage-Dependent Calcium Channels for the Treatment of Nervous System Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Vasculogenesis of the Embryonic Heart: Contribution of Nucleated Red Blood Cells to Early Vascular Structures
Cardiovascular & Hematological Disorders-Drug Targets SHP-2 Regulates Growth Factor Dependent Vascular Signalling and Function
Mini-Reviews in Medicinal Chemistry Leukocytes in Diabetic Retinopathy
Current Diabetes Reviews Pharmacotherapeutic Approach to Prevent or Treat Chronic Allograft Nephropathy
Current Drug Targets - Cardiovascular & Hematological Disorders Impact of Diabetes on Vasculature: Focus on Nervous System
Current Diabetes Reviews